
Electrochimica Acta p. 4281 - 4286 (2011)
Update date:2022-08-25
Topics:
Huang
Tian
Zhang
Gan
Tao
Xia
Tu
Highly porous nickel oxide (NiO) thin films were prepared on ITO glass by chemical bath deposition (CBD) method. SEM results show that the as-deposited NiO film is constructed by many interconnected nanoflakes with a thickness of about 20 nm. The electrochromic properties of the NiO film were investigated in a nonaqueous LiClO4-PC electrolyte by means of optical transmittance, cyclic voltammetry (CV) and electrochemical impedance spectroscopy (EIS) measurements. The NiO film exhibits a noticeable electrochromic performance with a variation of transmittance up to 38.6% at 550 nm. The CV and EIS measurements reveal that the NiO film has high electrochemical reaction activity and reversibility due to its highly porous structure. The electrochromic (EC) window based on complementary WO3/NiO structure shows an optical modulation of 83.7% at 550 nm, much higher than that of single WO3 film (65.5% at 550 nm). The response time of the EC widow is found to be about 1.76 s for coloration and 1.54 s for bleaching, respectively. These advantages such as large optical modulation, fast switch speed and excellent cycle durability make it attractive for a practical application.
View More
Reliable Pharma Technology (Shanghai) Co., Ltd.
Contact:0086-21-67676847-8008
Address:Lane 1500, No.68, Xinfei Road, Songjiang District, Shanghai, 201611, P.R.China.
Changsha Nutritopper Bio Technology Co.,Ltd.
Contact:+86-731-87803543
Address:East 1st Street, Baima Road, Ningxiang County
ZhangJiaGang YaRui Chemical Co.,Ltd.
Contact:0512-58360968
Address:China JiangSu Province Zhang Jia Gang City YangShe Oriental Plaza Building 10 B307
Beijing ZhongDaXinHe Chemical Product Co.,Ltd(expird)
Contact:010-52876516
Address:tongzhoubeiyuan
Contact:86-551-63540590
Address:No 1388 Furong Rd., Hefei, Anhui, China
Doi:10.1021/jo501576e
(2014)Doi:10.1021/ja107245k
(2011)Doi:10.1021/jo00936a040
(1974)Doi:10.1039/c4ta00490f
(2014)Doi:10.1039/c5ra08482b
(2015)Doi:10.1016/j.ijpharm.2020.119335
(2020)